Biotechnology

Rentschler  brings single-use system online

Rentschler brings single-use system online

By Gareth Macdonald

Rentschler Biotechnologie has increased single-use bioreactor capacity at its manufacturing site in Laupheim, Germany and is moving forward with plans to invest €25m ($27m) in a new stainless steel system in the next few months.

Baxter plans new US R&D headquarters

Baxter Transitions Biopharma R&D to a New Hub in Cambridge

By Agnes Shanley

Baxter International plans to set up a new global R&D center in Cambridge, Mass, for Baxalta, its biopharmaceuticals spinoff, which is expected be formally incorporated next year and headquartered in northern Illinois. 

Catalent commits to ADCs by upping its stake in Redwood

News from Interphex 2014

Catalent commits to ADCs by upping its stake in Redwood

By Dan Stanton

Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.

Sanofi to sell Paris R&D park

Sanofi to sell Paris R&D park

Sanofi has agreed to sell a life sciences park it owns on in Paris, France to public investment group, Caisse de Depots (CDC).

BioPharma News Vital says MIT prof

Keeping Up With The News Vital For BioPharmas Says MIT Prof

By Gareth Macdonald

Knowing about manufacturing innovations as soon as possible is more important for BioPharmas than for their small molecule counterparts according to an MIT Professor interviewed by our new sister site BioPharma-Reporter.com

AB Technology Buys Angel's Edinburgh Assets

AB Technology Buys Angel's Edinburgh Assets

By Dan Stanton

As the dissolution of Angel continues, its core manufacturing facility has been bought by AB Technology ensuring long term operations and rescuing 23 jobs.

GE and iBio designing plant-cell based vaccine facility

GE and iBio designing plant-cell based vaccine facility

By Gareth Macdonald

GE Healthcare has started designing a vaccine manufacturing facility for an unnamed drug company, just days after expanding its collaboration with plant-cell production technology firm iBio.

Lonza continues viral manufacturing expansion

Lonza continues viral manufacturing expansion

Lonza is targeting the gene therapy sector through a new partnership with Avalanche Biotechnologies that will seek to outlicense viral vector tech and process development knowhow.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All